22/10/2026
A more complete view of human biology often begins by looking from more than one angle.
At HUPO 2026, our colleagues shared how mass spectrometry and Olink® proximity extension assay technology can work together to advance proteomics research. Mass spectrometry enables deep, high-throughput discovery, while Olink provides highly sensitive, targeted protein measurement. Together with genomic and health data, these complementary approaches can help researchers uncover insights that might otherwise remain hidden.
Initial findings from the PRECISE-SG100K study, presented at the conference, demonstrate that potential at population scale. Analysis of the first 10,000 participant samples identified more than 2,400 genetic-protein associations not previously reported across 12 reference studies, expanding the evidence available to investigate disease pathways, potential biomarkers and therapeutic targets.
Thermo Fisher was also recognized with the 2026 HUPO Science & Technology Award for advancing targeted quantitation through the Thermo Scientific™ Stellar™ mass spectrometer. By bringing high sensitivity, selectivity, speed and intelligent data acquisition together in one platform, Stellar MS supports reproducible quantitation across tens to thousands of surrogate peptides. Automated workflows also help reduce method-development time, enabling researchers to move more efficiently from biomarker discovery to verification.
This recognition reflects our commitment to helping scientists generate high-quality proteomics data with greater confidence and efficiency. We’re grateful to our colleagues and to the researchers whose questions and collaboration continue to move the field forward.
